Tetrahydrocannabinolic acid, or THCA, is an acidic cannabinoid that precedes THC. Unlike THC, THCA is a non-psychoactive compound found in raw cannabis. Through the use of heat to initiate decarboxylation, THCA converts into THC, which does produce psychoactive properties. Although THCA is not as well studied as THC, research is beginning to suggest that THCA may provide significant therapeutic benefits. Preliminary research suggests THCA may provide anti-inflammatory effects, which could benefit a wide range of conditions including arthritis and lupus. It may also contain neuroprotective properties, which could help those suffering from neurodegenerative diseases. THCA may supply anti-emetic properties for nausea or appetite loss, and it may also be anti-proliferative, which is relevant for prostate cancer. Patient testimonies also suggest THCA may provide relief for insomnia, muscle spasms, and pain. This information may provide hope for seeking relief, but there is still much to be desired when it comes to research surrounding THCA and its potential benefits.
This information has been provided by Leafly and approved by our Chief Medical Officer.